Key facts
- It has raised $220K; the latest was Seed Round ($220K) in Jan 2025.
- Notable investors include Antler.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for APM Medichem
- ·The full record, as it builds
Funding rounds
No funding rounds for APM Medichem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About APM Medichem
Manufacturer of pharmaceutical and nutraceutical products intended to strengthen domestic and global healthcare supply chains. The company offers integrated WHO-GMP certified manufacturing, regulatory compliance capabilities, agile minimum order quantities, global sourcing of API and nutraceutical ingredients, and export readiness for rest-of-world and semi-regulated markets, enabling pharma and nutraceutical brands to access compliant manufacturing and delivery with improved speed-to-market and cost.
- Sector
- Healthcare
- HQ
- Panchkula, India
- Founded
- 2024
- Website
- apmmedichem.co.in/
- Ownership
- Privately Held (backing)
APM Medichem doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in APM Medichem shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on APM Medichem in its N-PORT filings yet. We sweep new filings monthly.